KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Liabilities and Shareholders Equity (2016 - 2025)

Medpace Holdings' Liabilities and Shareholders Equity history spans 11 years, with the latest figure at $2.0 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 5.97% year-over-year to $2.0 billion; the TTM value through Dec 2025 reached $7.2 billion, down 8.9%, while the annual FY2025 figure was $2.0 billion, 5.97% down from the prior year.
  • Liabilities and Shareholders Equity reached $2.0 billion in Q4 2025 per MEDP's latest filing, up from $1.8 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.1 billion in Q4 2024 to a low of $1.3 billion in Q2 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2021.
  • Peak YoY movement for Liabilities and Shareholders Equity: dropped 18.52% in 2022, then surged 40.18% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.7 billion in 2021, then decreased by 18.52% to $1.4 billion in 2022, then rose by 22.5% to $1.7 billion in 2023, then rose by 26.8% to $2.1 billion in 2024, then dropped by 5.97% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Liabilities and Shareholders Equity are $2.0 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.6 billion (Q2 2025).